@article{10912,
  keywords = {Anabolic drug, Anti-resorptive drug, Osteoporosis, Persistence, Switching},
  author = {E. Tan and D. Robinson and A. Jödicke and M. Mosseveld and K. Bødkergaard and C. Reyes and A. Moayyeri and A. Voss and E. Marconi and F. Lapi and J. Reinold and K. Verhamme and L. Pedersen and M. Braitmaier and M. de Wilde and M. Ruiz and M. Aragón and P. Bosco-Levy and R. Lassalle and D. Prieto-Alhambra and M. Sanchez-Santos},
  title = {Drug utilization analysis of osteoporosis medications in seven European electronic health databases},
  year = {2023},
  journal = {Osteoporos Int},
  edition = {2023/07/12},
  isbn = {0937-941x},
  doi = {10.1007/s00198-023-06837-0},
  note = {1433-2965
Tan, Eng Hooi
Robinson, Danielle E
Jödicke, Annika M
Mosseveld, Mees
Bødkergaard, Katrine
Reyes, Carlen
Moayyeri, Alireza
Voss, Annemarie
Marconi, Ettore
Lapi, Francesco
Reinold, Jonas
Verhamme, Katia M C
Pedersen, Lars
Braitmaier, Malte
de Wilde, Marcel
Ruiz, Marc Far
Aragón, María
Bosco-Levy, Pauline
Lassalle, Regis
Prieto-Alhambra, Daniel
Orcid: 0000-0002-3950-6346
Sanchez-Santos, Maria T
Journal Article
England
Osteoporos Int. 2023 Jul 12. doi: 10.1007/s00198-023-06837-0.},
  language = {eng},
}